Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study

N Furusyo1, J Hayashi, K Kakuda

  • 1Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan.

Insights

Newly acquired hepatitis C virus (HCV) infection continues in hemodialysis patients despite blood screening. Abnormal ALT levels in these patients are linked to HCV chronicity, highlighting ongoing transmission risks.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Nephrology

Background:

  • Hepatitis C virus (HCV) screening of blood products was implemented in Japan in 1989.
  • Hemodialysis patients are at increased risk for HCV infection due to frequent medical procedures and potential blood exposure.

Purpose of the Study:

  • To determine the incidence of newly acquired HCV infection in hemodialysis patients.
  • To characterize the clinical features of these new HCV infections.
  • To assess the impact of anti-HCV screening on HCV acquisition in this population.

Main Methods:

  • Prospective survey of 269 hemodialysis patients from 1990 to 1998.
  • Serial serum samples analyzed for HCV RNA (RT-PCR) and anti-HCV (ELISA).
  • Follow-up over a mean period of 6.6 years.

Main Results:

  • Newly acquired HCV infection occurred in 15.4% of patients (26/169) without prior infection, with an annual incidence of 2.59%.
  • Only four patients had a history of blood transfusion, with one receiving transfusion after 1992.
  • Persistent HCV viremia was observed in 65.4% of infected patients, with prolonged ALT abnormalities in some, though ALT eventually normalized in all chronic cases.

Conclusions:

  • Newly acquired HCV infection remains a concern in hemodialysis patients even after anti-HCV blood product screening.
  • Abnormal alanine aminotransferase (ALT) levels in these patients are associated with HCV chronicity.
  • Ongoing vigilance and infection control measures are crucial in hemodialysis settings.
Abstract

Related Concept Videos

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...